CAM
QTTB icon

Cormorant Asset Management’s Q32 Bio QTTB Stock Holding History

Cormorant Asset Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-26,161
Closed -$5.04M – 110
2020
Q3 		$5.04M Sell
26,161
-4,395
-14% -$985K 0.19% 75
2020
Q2 		$8.36M Sell
30,556
-2,777
-8% -$740K 0.32% 61
2020
Q1 		$9.32M Buy
+33,333
New +$10.2M 0.43% 49
2019
Q4 		– Sell
-13,617
Closed -$4.44M – 80
2019
Q3 		$4.44M Sell
13,617
-3,050
-18% -$1.04M 0.27% 57
2019
Q2 		$5.87M Buy
+16,667
New +$6.55M 0.34% 59

Other funds holding QTTB

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cormorant Asset Management's QTTB Position: Q4 2020 in Review

Cormorant Asset Management sold out of Q32 Bio (QTTB) in Q4 2020, closing a stake of 26,161 shares — an estimated $5.04M sold.

Cormorant Asset Management first reported a position in QTTB in Q2 2019 and held it in 5 quarters. The position peaked at $9.32M in Q1 2020. 106 funds tracked by Wall St. Rank hold QTTB as of Q4 2020.

  • Cormorant Asset Management reported no remaining Q32 Bio position as of Q4 2020 after selling out during the quarter.
  • Cormorant Asset Management sold 26,161 Q32 Bio shares in Q4 2020, an estimated $5.04M.
  • Cormorant Asset Management first reported a position in Q32 Bio in Q2 2019 and held it in 5 quarters.
  • Cormorant Asset Management's Q32 Bio position peaked at $9.32M in Q1 2020.
  • 106 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2020.

Based on Cormorant Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.